17 October 2016

BTG general counsel Paul Mussenden

From legal counsel to general counsel, Paul Mussenden has never looked back since joining speciality pharmaceuticals company BTG over 16 years ago. And with a PhD in molecular biology and microbial physiology, he can certainly be considered qualified for the job.

Nordics: Time to shake up the partnership model

Revenues grew substantially for some independent Nordic firms in 2015 and dropped for others, according to this year’s The Lawyer Euro 100, but behind the mixed results is a seismic change in the major firms’ internal structures.

The best law firm tech to understand your clients’ needs

There is a fundamental problem with ­innovation in the legal market. As one general counsel pointed out at The Lawyer’s recent Business Leadership Summit, clients understand why technology is a priority to improve the efficiency for their advisers, but it’s not a selling point. After all, what do they get out of it?

Ukraine: A land of opportunities for those who can handle risk

Acursory glance at the headlines would deter anyone from investing in Ukraine. Those not in the know could be forgiven for believing the country is besieged by the Russian military, tangled in a complex web of red tape and bureaucracy, and plagued by corruption and bribery.